Case Report: Concomitant coronary stent and femoral artery thrombosis in the setting of heparin-induced thrombocytopenia.
Key words: heparin; thrombocytopenia; thrombosis; coronary artery; stent; myocardial infarction; femoral artery; coronary angioplasty; thrombectomy
Journal
F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320
Informations de publication
Date de publication:
2019
2019
Historique:
accepted:
14
05
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
13
6
2020
Statut:
epublish
Résumé
Heparin induced thrombocytopenia (HIT) is a rare but potentially life threatening adverse drug reaction. We report an unusual case of concomitant subacute coronary stent and femoral artery thrombosis secondary to HIT. In the current era of extensive growth of heparin use and percutaneous coronary interventions, it's important for clinicians to remember that such complication might occur and should be prevented.
Identifiants
pubmed: 31316756
doi: 10.12688/f1000research.19041.1
pmc: PMC6611129
doi:
Substances chimiques
Heparin
9005-49-6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
667Déclaration de conflit d'intérêts
No competing interests were disclosed.
Références
Blood. 2005 Oct 15;106(8):2710-5
pubmed: 15985543
Hematology Am Soc Hematol Educ Program. 2006;:408-14
pubmed: 17124091
Korean Circ J. 2012 Sep;42(9):646-9
pubmed: 23091513
N Engl J Med. 2015 Jul 16;373(3):252-61
pubmed: 26176382
N Engl J Med. 2017 May 25;376(21):2053-2064
pubmed: 28538121
Blood. 2017 Aug 31;130(9):1104-1113
pubmed: 28646118
J Cardiol Cases. 2017 Mar 07;15(5):145-149
pubmed: 30279763
Blood Adv. 2018 Nov 27;2(22):3360-3392
pubmed: 30482768